These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1435321)

  • 1. 5-[3H]hydroxytryptamine and [3H]lysergic acid diethylamide binding to human platelets.
    Peters JR; Geaney DP; Grahame-Smith DG
    Methods Enzymol; 1992; 215():201-13. PubMed ID: 1435321
    [No Abstract]   [Full Text] [Related]  

  • 2. The 5-hydroxytryptamine receptor of blood platelets.
    Pletscher A; Affolter H
    J Neural Transm; 1983; 57(4):233-42. PubMed ID: 6655466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin 5-HT2A receptor binding in platelets from healthy subjects as studied by [3H]-lysergic acid diethylamide ([3H]-LSD): intra- and interindividual variability.
    Spigset O; Mjörndal T
    Neuropsychopharmacology; 1997 Apr; 16(4):285-93. PubMed ID: 9094146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
    Arora RC; Meltzer HY
    Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
    Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I
    Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.
    Schächter M; Geaney DP; Grahame-Smith DG; Cowen PJ; Elliott JM
    Br J Clin Pharmacol; 1985 Apr; 19(4):453-7. PubMed ID: 2859873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased platelet 3H-imipramine binding sites in classical migraine.
    Geaney DP; Rutterford MG; Elliott JM; Schächter M; Peet KM; Grahame-Smith DG
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):720-3. PubMed ID: 6086845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity binding of [3H]6-nitroquipazine to 5-hydroxytryptamine transporter in human platelets.
    Hashimoto K; Goromaru T
    Eur J Pharmacol; 1990 Oct; 187(3):295-302. PubMed ID: 2073917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic localization and characterization of [125I]lysergic acid diethylamide binding to serotonin receptors in Aplysia.
    Kadan MJ; Hartig PR
    Neuroscience; 1988 Mar; 24(3):1089-102. PubMed ID: 3380298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet [125I]R-DOI binding sites. Characterization by in vitro autoradiography.
    Himeno A; Saavedra JM
    Neuropsychopharmacology; 1990 Feb; 3(1):25-32. PubMed ID: 2306333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 5-hydroxytryptamine binding sites in the plasma membrane of pig blood platelets.
    Hoffmann D; Wesemann W
    J Neural Transm; 1985; 61(3-4):193-218. PubMed ID: 3157778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells.
    Carrick T; Kowal D; Nawoschik S; Zhang G; Chan K; Dunlop J
    Anal Biochem; 2008 Oct; 381(1):27-32. PubMed ID: 18601889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
    Boess FG; Riemer C; Bös M; Bentley J; Bourson A; Sleight AJ
    Mol Pharmacol; 1998 Sep; 54(3):577-83. PubMed ID: 9730917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of [3H]-5-hydroxytryptamine to homogenates of human brain.
    Dehlin E; Marcusson J; Fowler CJ; Winblad B
    J Neural Transm; 1982; 54(1-2):91-103. PubMed ID: 7108513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin binding in human platelets.
    Schick PK; McKean ML
    Biochem Pharmacol; 1979 Sep; 28(17):2667-70. PubMed ID: 518679
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors.
    Brazell C; McClue SJ; Preston GC; King B; Stahl SM
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):17-24. PubMed ID: 1772986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. d-[3H]Lysergic acid diethylamide binding to serotonin receptors in the molluscan nervous system.
    Drummond AH; Bucher F; Levitan IB
    J Biol Chem; 1980 Jul; 255(14):6679-86. PubMed ID: 7391044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.